Skip to main content
. 2014 Apr 15;472(8):2477–2482. doi: 10.1007/s11999-014-3621-y

Table 2.

Indications for revision among the three implants

Implant Type Infection, number (%) Loosening, number (%) Instability, number (%) Stiffness, number (%) Other, number (%) Total number
Genesis® II, Smith & Nephew, Memphis, TN, USA 41 (41.8) 15 (15.3) 10 (10.2) 21 (21.4) 11 (11.2) 98
NexGen®, Zimmer, Warsaw, IN, USA 47 (32.6) 27 (18.8) 41 (28.5) 24 (16.7) 5 (3.5) 144
Optetrak®, Exactech, Gainesville, FL, USA 48 (33.8) 13 (9.2) 43 (30.3) 22 (15.5) 16 (11.3) 142